A foretaste for pediatric glioblastoma therapy: targeting the NF-kB pathway with DHMEQ (2023)
Source: Child's Nervous System. Unidades: FFCLRP, FMRP
Subjects: GLIOMA, CRIANÇAS, RADIOTERAPIA, APOPTOSE, LINHAGEM CELULAR
ABNT
ANNICHINI, María Sol Brassesco et al. A foretaste for pediatric glioblastoma therapy: targeting the NF-kB pathway with DHMEQ. Child's Nervous System, v. 39, n. 6, p. 1519-1528, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00381-023-05878-4. Acesso em: 25 ago. 2024.APA
Annichini, M. S. B., Roberto, G. M., Delsin, L. E. A., Baldissera, G. C., Medeiros, M., Umezawa, K., & Tone, L. G. (2023). A foretaste for pediatric glioblastoma therapy: targeting the NF-kB pathway with DHMEQ. Child's Nervous System, 39( 6), 1519-1528. doi:10.1007/s00381-023-05878-4NLM
Annichini MSB, Roberto GM, Delsin LEA, Baldissera GC, Medeiros M, Umezawa K, Tone LG. A foretaste for pediatric glioblastoma therapy: targeting the NF-kB pathway with DHMEQ [Internet]. Child's Nervous System. 2023 ; 39( 6): 1519-1528.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1007/s00381-023-05878-4Vancouver
Annichini MSB, Roberto GM, Delsin LEA, Baldissera GC, Medeiros M, Umezawa K, Tone LG. A foretaste for pediatric glioblastoma therapy: targeting the NF-kB pathway with DHMEQ [Internet]. Child's Nervous System. 2023 ; 39( 6): 1519-1528.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1007/s00381-023-05878-4